Evidence‑Based Guidelines for Using the Visual Analogue Scale (VAS) in Pain Assessment

Definition, Scoring, and Clinical Interpretation

• The American Society of Anesthesiologists defines the VAS as a 100 mm horizontal line anchored by “no pain” (0 mm) and “worst imaginable pain” (100 mm); pain intensity is categorized as 0‑4 mm (no pain), 5‑44 mm (mild), 45‑74 mm (moderate), and 75‑100 mm (severe) to guide analgesic interventions. 1

Clinically Meaningful Change (Minimal Clinically Important Difference)

• In adult patients undergoing any analgesic intervention, a reduction of ≥10 mm on the 100 mm VAS (equivalent to ≥1 point on a 0‑10 numeric scale) constitutes the minimal clinically important difference (MCID) that patients perceive as a meaningful improvement. This threshold is supported by the strongest available evidence within the ASA guideline. 1
• Although literature reports MCID values ranging from 8 mm to 40 mm, the ASA guideline identifies the 10 mm threshold as the most robust and recommended standard. 1

Limitations of the VAS and Recommended Alternatives

• The VAS requires reliable verbal or visual communication; it is unsuitable for patients with aphasia, altered consciousness, or any inability to self‑report pain. This limitation is highlighted in the Critical Care Medicine recommendations. [2][3]4
• In intensive‑care settings, a 0‑10 Numeric Rating Scale (NRS) presented in visual format achieves a higher success rate (≈ 91 %) compared with the traditional horizontal VAS (≈ 66 %). Consequently, the NRS is the preferred self‑report tool for ICU patients. [2][3]4
• For patients who cannot self‑report, clinicians should employ validated behavioral pain scales such as the Critical‑Care Pain Observation Tool (CPOT) or the Behavioral Pain Scale – Non‑Intubated (BPS‑NI). These tools are recommended by the same Critical Care Medicine guidance. [2][3]

Application in Post‑Operative Analgesic Decision‑Making (ASA Guidance)

• Post‑operative patients with a VAS ≤30 mm (≈ ≤3/10) rarely request additional analgesia (≈ 4 %); the current regimen is considered adequate.
• Patients with a VAS 31‑70 mm (≈ 3‑7/10) have a moderate likelihood of requesting additional analgesia (≈ 43 %); clinicians should assess whether the VAS has decreased by ≥10 mm to determine the need for an intervention.
• Patients with a VAS >70 mm (≈ >7/10) overwhelmingly request further analgesia (≈ 80 %); immediate analgesic escalation is indicated.

(The above decision thresholds are derived from ASA clinical practice recommendations and are intended to align analgesic targets with patient‑reported pain intensity.)

All facts are drawn from peer‑reviewed guidelines and represent the most current, evidence‑based recommendations for VAS use in pain assessment.